The New World ID: Proof of Human for the AI Era Scales Across the Digital Platforms People and Businesses Use Every Day
24.4.2026 03:20:00 EEST | Business Wire | Press release
Last week, World announced the next generation of World ID, its proof of human protocol, designed to increase trust on the internet. The announcement was made during “Lift Off,” a live event in San Francisco.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260417530721/en/
Docusign, Okta, Tinder, Vercel, and Zoom bring World ID proof of human to businesses, AI agents, and consumers
As AI makes it easier than ever to generate convincing content, identities, and interactions, trust online has decreased. World ID addresses this challenge by enabling individuals to privately prove they are a real, unique human, without revealing their identity across apps, platforms, and services.
“If anything online can be faked, you no longer know who or what to trust,” said Tiago Sada, Chief Product Officer at Tools for Humanity, a company building tools for World. “World ID, which has already been used more than 450 million times, is designed to solve that at the root with a simple, privacy-preserving way to prove there’s a real human behind every interaction.”
A Full-Stack Upgrade for Proof of Human
The new World ID introduces an account-based architecture that makes proof of human more secure, more flexible, and ready for widespread adoption across consumer and enterprise use cases.
Key capabilities include:
- Account-based design: Enabling persistent, portable proof of human across apps and services;
- Key rotation and recovery: Improving security and usability for real-world use;
- Multi-key and session support: Allowing seamless authentication across devices and environments;
- Enhanced privacy protections: Strengthening anonymity through one-time-use nullifiers; and
- Open ecosystem: Opening integration to any developer through a new open-source SDK.
World ID for Business: Verifying Humans in High-Stakes Workflows
World ID is expanding to enterprise environments, where verifying that the correct human is taking an action is increasingly critical.
In communication and collaboration tools, identity assurance is becoming essential as deepfakes improve.
Zoom:Zoom is the first communications platform to offer integration of Deep Face directly into its meetings product. The integration delivers a hardware-backed root of trust through a three-way match: the cryptographically signed image taken when the participant originally verified at an Orb, a real-time Face Auth liveness selfie taken on the participant's device, and the live video frame that other participants see on screen. When all three match, the result is confirmation, with high assurance, that the person on the call is the real, verified human who is expected. The integration analyzes video only, not audio.
In digital agreements, the need to tie actions back to a real person is equally important.
Docusign: Docusign and World are teaming up to bring proof of human into the document signing trust model. Through World ID, signers can confirm specific attributes about themselves, proving they are human and not a bot. This establishes a foundation for human continuity in agreement workflows – giving actions, whether performed directly or delegated, ties back to a verified human.
These use cases address growing risks around impersonation, fraud, and AI-generated deception in business-critical interactions.
World ID for Agents: Human Verification in an Automated World
As AI agents increasingly act on behalf of individuals, verifying the human behind those agents becomes essential.
World is introducing new capabilities to ensure a human remains involved at critical moments in automated workflows, including "human in the loop."
World is teaming up with Vercel to bring human in the loop to developers building on Vercel's new open-source Workflow SDK. Developers can add a step to any workflow or agent to require human verification, and every verification is viewable inside each workflow execution for full auditability. The result is a provable record that a human was in the loop when it mattered most. This feature is live today, and it can be installed from npm.
World is also working with Okta to define how humans and agents interact.
Okta is planning to build a new product: Human Principal. Human Principal will allow API builders to verify whether a human stands behind an agent and its actions, and enforce policies accordingly. Humans will be able to verify themselves using a number of verification methods, and obtain device-bound cryptographic proof that carries across products without requiring cumbersome re-verification. World ID, slated to become one of the first Human Principal integration partners, is set to provide Human Principal with a privacy-preserving, user-friendly, and ubiquitous proof of human verification method.*
Once combined, World ID and Human Principal will enable features like rate limits per human for agent traffic, abuse-protected free tiers, and a cleaner onboarding flow for agents that need to access services on behalf of their human principal. The waitlist to join the upcoming Human Principal beta is now open at humanprincipal.ai.
These tools create a verifiable link between human intent and automated execution in the emerging agentic web.
World ID for People: Bringing Trust to Everyday Platforms
World ID is also expanding across the platforms people use every day, especially where authenticity and fairness matter most. One example is online dating, where trust is fundamental to how people connect.
Last year, World and Match Group launched a World ID pilot with Tinder in Japan, providing individuals with a privacy-preserving way to help confirm there is a real human behind the profile. Today, that integration expands on Tinder in select markets, including Japan and the United States, bringing proof of human to Tinder at scale. The experience is simple: verify with an Orb once, connect your Tinder account, stand out with a verified human badge and increase higher-quality connections by showing you’re real, and for a limited time, receive five free Boosts on Tinder, a paid in-app feature that makes your profile one of the top profiles in your local area. That kind of confidence changes how people show up, and when people show up authentically, better connections follow.
Live events are one of the most visible places where dreaded bots cost real fans real money. World also introduced Concert Kit, a new product that allows artists to reserve tickets for verified humans. Artists are already committing to piloting Concert Kit. Thirty Seconds to Mars will reserve a portion of tickets for verified humans on their upcoming 2027 tour, with more details to come. Some reports suggested that Tools for Humanity has a partnership or commercial relationship with Bruno Mars, ‘The Romantic Tour,’ or Live Nation. This is not the case. There is no business relationship, agreement, or collaboration of any kind between Tools for Humanity, World or its related products and these parties.
About World
World is intended to be the world’s largest, most inclusive network of real humans. The project was originally conceived by Sam Altman, Max Novendstern, and Alex Blania and aims to provide proof of human, finance and connection for every human in the age of AI. Find out more about World at world.org and on X.
*Any mention of future products, features, functionalities, or certifications in this press release is for informational purposes only. These items are not commitments to deliver and should not be relied upon to make purchasing decisions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260417530721/en/
Contacts
press contact: press@world.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom